Document Detail


Intrascleral drug delivery to the eye using hollow microneedles.
MedLine Citation:
PMID:  18979189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: This study tested the hypothesis that hollow microneedles can infuse solutions containing soluble molecules, nanoparticles, and microparticles into sclera in a minimally invasive manner.
METHODS: Individual hollow microneedles were inserted into, but not across, human cadaver sclera and aqueous solutions containing sulforhodamine or fluorescently tagged nanoparticles or microparticles were infused into sclera at constant pressure. The infused volume of fluid was measured and imaged histologically as a function of scleral thickness, infusion pressure, needle retraction depth and the presence of spreading enzymes (hyaluronidase and collagenase).
RESULTS: Individual hollow microneedles were able to insert into sclera. Fluid infusion was extremely slow after microneedle insertion into the sclera without retraction, but partial retraction of the microneedle over a distance of 200-300 microm enabled infusion of 10-35 microl of fluid into the tissue. Scleral thickness and infusion pressure had insignificant effects on fluid delivery. Nanoparticle suspensions were also delivered into sclera, but microparticles were delivered only in the presence of hyaluronidase and collagenase spreading enzymes, which suggested the role of scleral glycosaminoglycans and collagen fibers as rate-limiting barriers.
CONCLUSION: This study shows that hollow microneedles can infuse solutions into the sclera for minimally invasive delivery of soluble molecules, nanoparticles and microparticles.
Authors:
Jason Jiang; Jason S Moore; Henry F Edelhauser; Mark R Prausnitz
Related Documents :
9797519 - Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged c...
7243769 - Response of the vascular system to different modifications of haemofiltration and haemo...
1877349 - Oedema-preventing mechanisms in a low-compliant tissue: studies on the rat tail.
7233429 - A fluid dynamical theory of microexplosion for medicine and biology.
3989719 - Effect of fluid pressure on the hydraulic conductance of interstitium and fenestrated e...
17096869 - Can passive leg raising be used to guide fluid administration?
8222819 - Temporal hemodynamic and oxygen transport patterns in medical patients. septic shock.
6408049 - Effect of hypoxia and hypercapnia on catecholamine content in cat carotid body.
22316729 - An approach to aircraft seat comfort using interface pressure mapping.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, N.I.H., Extramural     Date:  2008-11-01
Journal Detail:
Title:  Pharmaceutical research     Volume:  26     ISSN:  0724-8741     ISO Abbreviation:  Pharm. Res.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-19     Completed Date:  2009-03-23     Revised Date:  2014-09-16    
Medline Journal Info:
Nlm Unique ID:  8406521     Medline TA:  Pharm Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  395-403     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cadaver
Collagenases / metabolism
Equipment Design
Fibrillar Collagens / metabolism
Glycosaminoglycans / metabolism
Humans
Hyaluronoglucosaminidase / metabolism
Microinjections / instrumentation*
Nanoparticles
Needles
Particle Size
Pressure
Rhodamines / administration & dosage*,  chemistry,  metabolism
Sclera / metabolism*
Grant Support
ID/Acronym/Agency:
R01 EB000260/EB/NIBIB NIH HHS; R01 EB000260-03/EB/NIBIB NIH HHS; R01 EB000260-04/EB/NIBIB NIH HHS; R01 GM060004/GM/NIGMS NIH HHS; R01 GM060004-01A1/GM/NIGMS NIH HHS; R01 GM060004-02/GM/NIGMS NIH HHS; R01 GM060004-03/GM/NIGMS NIH HHS; R24 EY017045-01/EY/NEI NIH HHS; R24 EY017045-02/EY/NEI NIH HHS; R24 EY017045-03/EY/NEI NIH HHS; R24-EY-017045/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
0/Fibrillar Collagens; 0/Glycosaminoglycans; 0/Rhodamines; EC 3.2.1.35/Hyaluronoglucosaminidase; EC 3.4.24.-/Collagenases; EC 3.4.24.-/collagenase 1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairin...
Next Document:  Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for...